Genvor Appoints Donald Kalkofen as Chief Financial Officer
Genvor, Inc., a biotechnology company focused on AI-generated peptides for agriculture and human health solutions, has appointed Donald Kalkofen as its new CFO. With over two decades of experience in finance leadership across public companies and IPOs, Kalkofen is expected to support Genvor's dual-market growth strategy.
Tickers: $SYMC
Topics: Biotechnology CFO Hiring Leadership Change